{"transactions":[{"id":725476,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:15:20.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of June 24, 2027 or the date of the Issuer's 2027 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":10.54,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001580787-26-000004","document":"form4-06262026_040614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000158078726000004/form4-06262026_040614.xml","form_type":"4"}},{"id":951750,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock option (right to buy)","published_at":"2026-01-05T21:08:50.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2027, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":750000,"derivative":{"exercise_price":9.1,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001580787-26-000002","document":"form4-01052026_090147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000158078726000002/form4-01052026_090147.xml","form_type":"4"}},{"id":972712,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock option (right to buy)","published_at":"2025-12-11T21:30:27.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 1, 2023, the Reporting Person was granted an option to purchase 525,000 shares of common stock.  25% of the shares subject to the option would vest on August 25, 2024, and thereafter the balance would vest in equal monthly installments over the following 36 months, provided that, as an additional condition, no shares under the option would vest until the Issuer achieved a specific performance condition. On December 9, 2025, the Issuer's Board of Directors deemed that the performance condition had been met, resulting in vesting of the option as to 295,312 shares. The remainder of the unvested shares subject to the option shall vest monthly through August 25, 2027 subject to the continuous service of the Reporting Person through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 1, 2023, the Reporting Person was granted an option to purchase 525,000 shares of common stock.  25% of the shares subject to the option would vest on August 25, 2024, and thereafter the balance would vest in equal monthly installments over the following 36 months, provided that, as an additional condition, no shares under the option would vest until the Issuer achieved a specific performance condition. On December 9, 2025, the Issuer's Board of Directors deemed that the performance condition had been met, resulting in vesting of the option as to 295,312 shares. The remainder of the unvested shares subject to the option shall vest monthly through August 25, 2027 subject to the continuous service of the Reporting Person through each such date."}],"balance_after":525000,"derivative":{"exercise_price":2.48,"underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001580787-25-000006","document":"form4-12112025_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000158078725000006/form4-12112025_041203.xml","form_type":"4"}},{"id":972711,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock option (right to buy)","published_at":"2025-12-11T21:30:27.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 1, 2023, the Reporting Person was granted an option to purchase 525,000 shares of common stock.  25% of the shares subject to the option would vest on August 25, 2024, and thereafter the balance would vest in equal monthly installments over the following 36 months, provided that, as an additional condition, no shares under the option would vest until the Issuer achieved a specific performance condition. On December 9, 2025, the Issuer's Board of Directors deemed that the performance condition had been met, resulting in vesting of the option as to 295,312 shares. The remainder of the unvested shares subject to the option shall vest monthly through August 25, 2027 subject to the continuous service of the Reporting Person through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 1, 2023, the Reporting Person was granted an option to purchase 525,000 shares of common stock.  25% of the shares subject to the option would vest on August 25, 2024, and thereafter the balance would vest in equal monthly installments over the following 36 months, provided that, as an additional condition, no shares under the option would vest until the Issuer achieved a specific performance condition. On December 9, 2025, the Issuer's Board of Directors deemed that the performance condition had been met, resulting in vesting of the option as to 295,312 shares. The remainder of the unvested shares subject to the option shall vest monthly through August 25, 2027 subject to the continuous service of the Reporting Person through each such date."}],"balance_after":525000,"derivative":{"exercise_price":2.48,"underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001580787-25-000006","document":"form4-12112025_041203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000158078725000006/form4-12112025_041203.xml","form_type":"4"}},{"id":998882,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T23:41:51.000Z","date":"2025-11-12","kind":"gift","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Pratik Shah Living Trust dated June 15, 2011"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction involved the transfer of shares to a charitable fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the trustee of The Pratik Shah Living Trust dated June 15, 2011."}],"balance_after":4474554,"source":{"system":"sec-edgar","filing":"0001580787-25-000004","document":"form4-11142025_111147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000158078725000004/form4-11142025_111147.xml","form_type":"4"}},{"id":998881,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T23:41:51.000Z","date":"2025-11-12","kind":"gift","planned":false,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Pratik Shah Living Trust dated June 15, 2011"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction involved the gift of shares to a trust in which the Reporting Person is not the trustee and the Reporting Person has no pecuniary interest over shares held in the trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the trustee of The Pratik Shah Living Trust dated June 15, 2011."}],"balance_after":4574554,"source":{"system":"sec-edgar","filing":"0001580787-25-000004","document":"form4-11142025_111147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000158078725000004/form4-11142025_111147.xml","form_type":"4"}},{"id":1100217,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-27T20:30:23.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":30000,"derivative":{"exercise_price":17.26,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-25-018386","document":"form4-06272025_040610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588925018386/form4-06272025_040610.xml","form_type":"4"}},{"id":1310876,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock option (right to buy)","published_at":"2025-01-07T00:00:31.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2026, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":600000,"derivative":{"exercise_price":6.17,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001415889-25-000878","document":"form4-01062025_070127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000141588925000878/form4-01062025_070127.xml","form_type":"4"}},{"id":1470702,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-24T21:00:19.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of June 20, 2025 or the date of the Issuer's 2025 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":40000,"derivative":{"exercise_price":7.73,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-018015","document":"form4-06242024_050614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924018015/form4-06242024_050614.xml","form_type":"4"}},{"id":1477315,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T22:39:03.000Z","date":"2024-06-13","kind":"gift","planned":false,"acquired":false,"shares":1132900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse of Pratik Shah, Ph.D."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved the gift by the Reporting Person's spouse to an irrevocable trust of which the Reporting Person's spouse is settlor."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-24-017260","document":"form4-06172024_100659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924017260/form4-06172024_100659.xml","form_type":"4"}},{"id":1477314,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-17T22:39:03.000Z","date":"2024-06-13","kind":"gift","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse of Pratik Shah, Ph.D."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved the gift of shares by the Reporting Person's spouse to the Reporting Person's father-in-law."}],"balance_after":1132900,"source":{"system":"sec-edgar","filing":"0001415889-24-017260","document":"form4-06172024_100659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924017260/form4-06172024_100659.xml","form_type":"4"}},{"id":1486797,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-08T01:11:17.000Z","date":"2024-06-07","kind":"gift","planned":false,"acquired":false,"shares":1332950,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Pratik Shah Living Trust dated June 15, 2011"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved the gift by The Pratik Shah Living Trust dated June 15, 2011 to The Pratik Shah Trust (the \"Shah Trust\") of which the Reporting Person's spouse is sole beneficiary. The Reporting Person is grantor of the Shah Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pratik Shah, Ph.D. is the trustee of The Pratik Shah Living Trust dated June 15, 2011."}],"balance_after":4824554,"source":{"system":"sec-edgar","filing":"0001415889-24-016095","document":"form4-06082024_010613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924016095/form4-06082024_010613.xml","form_type":"4"}},{"id":1486796,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90155,"kind":"organization","name":"Pratik Shah Living Trust dated June 15, 2011","position":2,"cik":"0001953388","reported_name":"Pratik Shah Living Trust dated June 15, 2011","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-08T01:09:10.000Z","date":"2024-06-04","kind":"other","planned":false,"acquired":false,"shares":2665800,"ownership":{"direct":false,"nature":"By The Pratik Shah Living Trust dated June 15, 2011"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Pratik Shah Living Trust dated June 15, 2011 transferred 1,332,900 shares to The Light Irrevocable Trust #1, of which an adult son of Pratik Shah, M.D. is a beneficiary, and 1,332,900 shares to The Star Irrevocable Trust #1, of which an adult son of Dr. Shah is a beneficiary.  Each transfer was made in exchange for trust assets of equal value under an asset substitution power authorized under the terms of each trust."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Pratik Shah Living Trust dated June 15, 2011 transferred 1,332,900 shares to The Light Irrevocable Trust #1, of which an adult son of Pratik Shah, M.D. is a beneficiary, and 1,332,900 shares to The Star Irrevocable Trust #1, of which an adult son of Dr. Shah is a beneficiary.  Each transfer was made in exchange for trust assets of equal value under an asset substitution power authorized under the terms of each trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pratik Shah, Ph.D. is the trustee of The Pratik Shah Living Trust dated June 15, 2011."}],"balance_after":7490404,"source":{"system":"sec-edgar","filing":"0001415889-24-016094","document":"form4a-06082024_010607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924016094/form4a-06082024_010607.xml","form_type":"4/A","original_submission_date":"2024-06-06"}},{"id":1488442,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90155,"kind":"organization","name":"Pratik Shah Living Trust dated June 15, 2011","position":2,"cik":"0001953388","reported_name":"Pratik Shah Living Trust dated June 15, 2011","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:32:47.000Z","date":"2024-06-04","kind":"gift","planned":false,"acquired":true,"shares":1332900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse of Pratik Shah, Ph.D."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved the reporting person's gift to his spouse."}],"balance_after":1332900,"source":{"system":"sec-edgar","filing":"0001415889-24-015769","document":"form4-06062024_080642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924015769/form4-06062024_080642.xml","form_type":"4"}},{"id":1488441,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90155,"kind":"organization","name":"Pratik Shah Living Trust dated June 15, 2011","position":2,"cik":"0001953388","reported_name":"Pratik Shah Living Trust dated June 15, 2011","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:32:47.000Z","date":"2024-06-04","kind":"gift","planned":false,"acquired":false,"shares":1332900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Pratik Shah Living Trust dated June 15, 2011"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved the reporting person's gift to his spouse."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pratik Shah, Ph.D. is the trustee of The Pratik Shah Living Trust dated June 15, 2011."}],"balance_after":6157504,"source":{"system":"sec-edgar","filing":"0001415889-24-015769","document":"form4-06062024_080642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924015769/form4-06062024_080642.xml","form_type":"4"}},{"id":1488440,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90155,"kind":"organization","name":"Pratik Shah Living Trust dated June 15, 2011","position":2,"cik":"0001953388","reported_name":"Pratik Shah Living Trust dated June 15, 2011","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:32:47.000Z","date":"2024-06-04","kind":"other","planned":false,"acquired":false,"shares":2665800,"ownership":{"direct":false,"nature":"By The Pratik Shah Living Trust dated June 15, 2011"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Pratik Shah Living Trust dated June 15, 2011 transferred 1,332,900 shares to The Light Irrevocable Trust #1 (the \"Light Trust\"), of which an adult son of Pratik Shah, M.D. is a beneficiary, and 1,332,900 shares to The Star Irrevocable Trust #1 (the \"Star Trust\"), of which an adult son of Dr. Shah is a beneficiary.  Dr. Shah is grantor of The Light Trust and the Star Trust and therefore has the ability to terminate each trust. Each transfer was made in exchange for trust assets of equal value under an asset substitution power authorized under the terms of each trust."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Pratik Shah Living Trust dated June 15, 2011 transferred 1,332,900 shares to The Light Irrevocable Trust #1 (the \"Light Trust\"), of which an adult son of Pratik Shah, M.D. is a beneficiary, and 1,332,900 shares to The Star Irrevocable Trust #1 (the \"Star Trust\"), of which an adult son of Dr. Shah is a beneficiary.  Dr. Shah is grantor of The Light Trust and the Star Trust and therefore has the ability to terminate each trust. Each transfer was made in exchange for trust assets of equal value under an asset substitution power authorized under the terms of each trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pratik Shah, Ph.D. is the trustee of The Pratik Shah Living Trust dated June 15, 2011."}],"balance_after":7490404,"source":{"system":"sec-edgar","filing":"0001415889-24-015769","document":"form4-06062024_080642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000141588924015769/form4-06062024_080642.xml","form_type":"4"}},{"id":1789346,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-05T21:33:07.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option will vest as follows provided that the Company initiates a Phase 2a clinical trial for a product candidate for the treatment of FA: 25% of the shares subject to the option will vest one year following August 25, 2023, and thereafter the balance of the shares will vest in equal monthly installments over the following 36 months."}],"balance_after":525000,"derivative":{"exercise_price":2.48,"expiration_date":"2033-08-31","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001209191-23-048222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123048222/doc4.xml","form_type":"4"}},{"id":1789345,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-05T21:33:07.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest as follows provided that an investigational new drug application for a product candidate for the treatment of Friedrich ataxia (\"FA\") submitted by the Issuer after September 1, 2023 receives clearance from the U.S. Food and Drug Administration: 25% of the shares subject to the option will vest one year following August 25, 2023, and thereafter the balance of the shares will vest in equal monthly installments over the following 36 months."}],"balance_after":525000,"derivative":{"exercise_price":2.48,"expiration_date":"2033-08-31","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0001209191-23-048222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123048222/doc4.xml","form_type":"4"}},{"id":1789344,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-05T21:33:07.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":1050000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest one year following August 25, 2023, and thereafter the balance of the shares will vest in equal monthly installments over the following 36 months."}],"balance_after":1050000,"derivative":{"exercise_price":2.48,"expiration_date":"2033-08-31","underlying":"Common Stock","underlying_shares":1050000},"source":{"system":"sec-edgar","filing":"0001209191-23-048222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123048222/doc4.xml","form_type":"4"}},{"id":1842707,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-29T01:00:44.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of June 27, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors."}],"balance_after":40000,"derivative":{"exercise_price":6.5,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-040112","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919123040112/doc4.xml","form_type":"4"}},{"id":2033210,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-03T21:40:48.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":415000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2024, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":415000,"derivative":{"exercise_price":7.97,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":415000},"source":{"system":"sec-edgar","filing":"0001209191-23-006917","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919123006917/doc4.xml","form_type":"4"}},{"id":2120062,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90155,"kind":"organization","name":"Pratik Shah Living Trust dated June 15, 2011","position":2,"cik":"0001953388","reported_name":"Pratik Shah Living Trust dated June 15, 2011","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-11-10T23:00:49.000Z","date":"2022-11-08","kind":"grant","acquired":true,"shares":354570,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in exchange for a stock option to acquire 300,000 shares of common stock of ARS with the exercise price of $1.70 per share pursuant to the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the closing of the Merger, each outstanding option to purchase shares of ARS common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in a series of thirty-six (36) equal monthly installments measured from the vesting commencement date."}],"balance_after":354570,"derivative":{"exercise_price":1.44,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":354570},"source":{"system":"sec-edgar","filing":"0001209191-22-056445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122056445/doc4.xml","form_type":"4"}},{"id":2120061,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90155,"kind":"organization","name":"Pratik Shah Living Trust dated June 15, 2011","position":2,"cik":"0001953388","reported_name":"Pratik Shah Living Trust dated June 15, 2011","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-11-10T23:00:49.000Z","date":"2022-11-08","kind":"grant","acquired":true,"shares":10156204,"ownership":{"direct":false,"nature":"By The Pratik Shah Living Trust dated June 15, 2011"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 8,593,116 shares of common stock of ARS Pharmaceuticals, Inc. (\"ARS\") pursuant to an Agreement and Plan of Merger and Reorganization by and among ARS, the Issuer and Sabre Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), as amended (the \"Merger Agreement\"). Under the terms of the Merger Agreement, on November 8, 2022, Merger Sub merged with and into ARS (the \"Merger\"), with ARS surviving the Merger as a wholly-owned subsidiary of the Issuer.  Upon the closing of the Merger, each share of ARS common stock was converted into the right to receive 1.1819 shares of the Issuer common stock.  Subsequent to the Merger, the name of the Issuer was changed from Silverback Therapeutics, Inc. to ARS Pharmaceuticals, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of the Reporting Person.  The Reporting Person is trustee of the trust."}],"balance_after":10156204,"source":{"system":"sec-edgar","filing":"0001209191-22-056445","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122056445/doc4.xml","form_type":"4"}},{"id":2416945,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T00:50:52.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest as follows: 20% of the shares will vest on February 1, 2023, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months."}],"balance_after":475000,"derivative":{"exercise_price":12.77,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001209191-22-006579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919122006579/doc4.xml","form_type":"4"}},{"id":2764488,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Series A Preferred Stock","published_at":"2021-04-01T22:16:01.000Z","date":"2021-03-30","kind":"exercise","acquired":false,"shares":171025,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pratik Shah Living Trust (6/15/2011)"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the Trustee of the Pratik Shah Living Trust (6/15/2011). The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":104923},"source":{"system":"sec-edgar","filing":"0001209191-21-024229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121024229/doc4.xml","form_type":"4"}},{"id":2764487,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2021-04-01T22:16:01.000Z","date":"2021-03-30","kind":"exercise","acquired":true,"shares":104923,"ownership":{"direct":false,"nature":"By Pratik Shah Living Trust (6/15/2011)"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect.  The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is the Trustee of the Pratik Shah Living Trust (6/15/2011). The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":129923,"source":{"system":"sec-edgar","filing":"0001209191-21-024229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121024229/doc4.xml","form_type":"4"}},{"id":2764486,"issuer":{"id":4991,"kind":"organization","name":"Design Therapeutics, Inc."},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2021-04-01T22:16:01.000Z","date":"2021-03-30","kind":"purchase","acquired":true,"shares":25000,"price":20,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were purchased in the Issuer's initial public offering."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001209191-21-024229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807120/000120919121024229/doc4.xml","form_type":"4"}},{"id":3302442,"issuer":{"id":152202,"kind":"organization","name":"Synthorx, Inc.","symbol":"THOR"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-24T23:38:48.000Z","date":"2020-01-23","kind":"disposition_to_issuer","acquired":false,"shares":10223,"price":55.6,"value":568398.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which provided for vesting of the shares in equal monthly installments over the 12 months following June 7, 2019, such that the option would be fully vested on the date of the Issuer's next annual stockholder meeting, was cancelled in connection with the merger of the Issuer with Sanofi's wholly owned subsidiary in exchange for a cash payment of $568,398.80, representing the difference between the exercise price of the option and the market value of the underlying common stock of the Issuer on the effective date of the merger ($68)."}],"balance_after":0,"derivative":{"exercise_price":12.4,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":10223},"source":{"system":"sec-edgar","filing":"0001209191-20-004928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580787/000120919120004928/doc4.xml","form_type":"4"}},{"id":3302441,"issuer":{"id":152202,"kind":"organization","name":"Synthorx, Inc.","symbol":"THOR"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T23:38:48.000Z","date":"2020-01-23","kind":"other","acquired":false,"shares":62412,"price":68,"value":4244016.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-004928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580787/000120919120004928/doc4.xml","form_type":"4"}},{"id":3495334,"issuer":{"id":152202,"kind":"organization","name":"Synthorx, Inc.","symbol":"THOR"},"owners":[{"id":35144,"kind":"person","name":"Shah Pratik","position":1,"cik":"0001580787","reported_name":"Shah Pratik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-10T22:37:51.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":10223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over the 12 months following June 7, 2019, provided that the option will be fully vested on the date of the Issuer's next annual stockholder meeting."}],"balance_after":10223,"derivative":{"exercise_price":12.4,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":10223},"source":{"system":"sec-edgar","filing":"0001209191-19-035968","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580787/000120919119035968/doc4.xml","form_type":"4"}}]}